{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:53:44Z","timestamp":1792079624733,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0084, PC200150"],"award-info":[{"award-number":["W81XWH-21-1-0084, PC200150"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75810-2","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:55:49Z","timestamp":1784904949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-partnered multiomics reveals the molecular architecture of angiosarcoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8630-3667","authenticated-orcid":false,"given":"Hoyin","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Hollyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany A.","family":"Borden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-0068","authenticated-orcid":false,"given":"Jorge","family":"G\u00f3mez Tejeda Za\u00f1udo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beena S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolbe","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-6486","authenticated-orcid":false,"given":"Erica Maria","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Y.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-4807","authenticated-orcid":false,"given":"Caleb A.","family":"Lareau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyin","family":"Alao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadley","family":"Grundman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Sterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Terzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan K.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McGillicuddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0220-3373","authenticated-orcid":false,"given":"Parker","family":"Chastain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Bhakhri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6475-8345","authenticated-orcid":false,"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0401-6619","authenticated-orcid":false,"given":"Hani","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8965-8874","authenticated-orcid":false,"given":"Diane M.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0201-4444","authenticated-orcid":false,"given":"Eliezer M.","family":"Van Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-9438","authenticated-orcid":false,"given":"Nikhil","family":"Wagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie A.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9062-3399","authenticated-orcid":false,"given":"Saud","family":"AlDubayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"75810_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","volume":"11","author":"RJ Young","year":"2010","unstructured":"Young, R. J., Brown, N. J., Reed, M. W., Hughes, D. & Woll, P. J. Angiosarcoma. Lancet Oncol. 11, 983\u2013991 (2010).","journal-title":"Lancet Oncol."},{"key":"75810_CR2","doi-asserted-by":"publisher","first-page":"e246235","DOI":"10.1001\/jamanetworkopen.2024.6235","volume":"7","author":"MJ Wagner","year":"2024","unstructured":"Wagner, M. J. et al. Incidence and presenting characteristics of angiosarcoma in the US, 2001-2020. JAMA Netw. Open 7, e246235 (2024).","journal-title":"JAMA Netw. Open"},{"key":"75810_CR3","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/annonc\/mdm381","volume":"18","author":"J Fayette","year":"2007","unstructured":"Fayette, J. et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann. Oncol. 18, 2030\u20132036 (2007).","journal-title":"Ann. Oncol."},{"key":"75810_CR4","first-page":"2303","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao, J., Wang, J., He, C. & Fang, M. Angiosarcoma: a review of diagnosis and current treatment. Am. J. Cancer Res. 9, 2303\u20132313 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"75810_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/COC.0b013e31827e4e7b","volume":"37","author":"D Buehler","year":"2014","unstructured":"Buehler, D. et al. Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am. J. Clin. Oncol. 37, 473\u2013479 (2014).","journal-title":"Am. J. Clin. Oncol."},{"key":"75810_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41591-019-0749-z","volume":"26","author":"CA Painter","year":"2020","unstructured":"Painter, C. A. et al. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat. Med. 26, 181\u2013187 (2020).","journal-title":"Nat. Med."},{"key":"75810_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30453-x","volume":"13","author":"BA Nacev","year":"2022","unstructured":"Nacev, B. A. et al. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets. Nat. Commun. 13, 3405 (2022).","journal-title":"Nat. Commun."},{"key":"75810_CR8","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1172\/JCI139080","volume":"130","author":"JY Chan","year":"2020","unstructured":"Chan, J. Y. et al. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma. J. Clin. Investig. 130, 5833\u20135846 (2020).","journal-title":"J. Clin. Investig."},{"key":"75810_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00753-2","volume":"12","author":"A Boichard","year":"2020","unstructured":"Boichard, A., Wagner, M. J. & Kurzrock, R. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing. Genome Med. 12, 61 (2020).","journal-title":"Genome Med."},{"key":"75810_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s42003-023-04856-5","volume":"6","author":"JW Loh","year":"2023","unstructured":"Loh, J. W. et al. Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma. Commun. Biol. 6, 461 (2023).","journal-title":"Commun. Biol."},{"key":"75810_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/bjc.2014.359","volume":"111","author":"E Styring","year":"2014","unstructured":"Styring, E. et al. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas. Br. J. Cancer 111, 407\u2013412 (2014).","journal-title":"Br. J. Cancer"},{"key":"75810_CR12","doi-asserted-by":"publisher","first-page":"101385","DOI":"10.1016\/j.tranon.2022.101385","volume":"19","author":"Y Wei","year":"2022","unstructured":"Wei, Y., Yang, X., Gao, L., Xu, Y. & Yi, C. Differences in potential key genes and pathways between primary and radiation-associated angiosarcoma of the breast. Transl. Oncol. 19, 101385 (2022).","journal-title":"Transl. Oncol."},{"key":"75810_CR13","doi-asserted-by":"publisher","first-page":"36041","DOI":"10.18632\/oncotarget.5936","volume":"6","author":"R Murali","year":"2015","unstructured":"Murali, R. et al. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway. Oncotarget 6, 36041\u201336052 (2015).","journal-title":"Oncotarget"},{"key":"75810_CR14","doi-asserted-by":"crossref","unstructured":"Espejo-Freire, A. P. et al. Genomic landscape of angiosarcoma: a targeted and immunotherapy biomarker analysis. Cancers 13, 4816 (2021).","DOI":"10.3390\/cancers13194816"},{"key":"75810_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40425-017-0263-0","volume":"5","author":"S Sindhu","year":"2017","unstructured":"Sindhu, S., Gimber, L. H., Cranmer, L., McBride, A. & Kraft, A. S. Angiosarcoma treated successfully with anti-PD-1 therapy - a case report. J. Immunother. Cancer 5, 58 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"75810_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9383","volume":"6","author":"O Calvete","year":"2015","unstructured":"Calvete, O. et al. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families. Nat. Commun. 6, 8383 (2015).","journal-title":"Nat. Commun."},{"key":"75810_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s42003-024-05798-2","volume":"7","author":"S Sharma","year":"2024","unstructured":"Sharma, S., Ehrlich, M., Zhang, M., Blobe, G. C. & Henis, Y. I. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting. Commun. Biol. 7, 112 (2024).","journal-title":"Commun. Biol."},{"key":"75810_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s12254-017-0365-x","volume":"10","author":"RJ Young","year":"2017","unstructured":"Young, R. J. & Woll, P. J. Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update. Memo 10, 190\u2013193 (2017).","journal-title":"Memo"},{"key":"75810_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal. Transduct. Target. Ther. 7, 265 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"75810_CR20","doi-asserted-by":"publisher","first-page":"185687","DOI":"10.1155\/2010\/185687","volume":"2010","author":"R Ria","year":"2010","unstructured":"Ria, R. et al. Angiogenesis and progression in human melanoma. Dermatol. Res. Pract. 2010, 185687 (2010).","journal-title":"Dermatol. Res. Pract."},{"key":"75810_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05389-8","volume":"7","author":"E Mintet","year":"2017","unstructured":"Mintet, E. et al. Endothelial Hey2 deletion reduces endothelial-to-mesenchymal transition and mitigates radiation proctitis in mice. Sci. Rep. 7, 4933 (2017).","journal-title":"Sci. Rep."},{"key":"75810_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20917-w","volume":"8","author":"L Miao","year":"2018","unstructured":"Miao, L. et al. Notch signaling regulates Hey2 expression in a spatiotemporal dependent manner during cardiac morphogenesis and trabecular specification. Sci. Rep. 8, 2678 (2018).","journal-title":"Sci. Rep."},{"key":"75810_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56834-6","volume":"16","author":"F Li","year":"2025","unstructured":"Li, F. et al. CHAMP1 complex directs heterochromatin assembly and promotes homology-directed DNA repair. Nat. Commun. 16, 1714 (2025).","journal-title":"Nat. Commun."},{"key":"75810_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2011.12.028","volume":"148","author":"J Hu","year":"2012","unstructured":"Hu, J. et al. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148, 651\u2013663 (2012).","journal-title":"Cell"},{"key":"75810_CR25","doi-asserted-by":"publisher","first-page":"zcaf056","DOI":"10.1093\/narcan\/zcaf056","volume":"7","author":"D Muoio","year":"2025","unstructured":"Muoio, D. & Fouquerel, E. The alternative lengthening of telomeres pathway through a DNA repair lens: mechanism and therapeutic opportunities. NAR Cancer 7, zcaf056 (2025).","journal-title":"NAR Cancer"},{"key":"75810_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s12276-020-0439-4","volume":"52","author":"KJ Choi","year":"2020","unstructured":"Choi, K. J., Nam, J.-K., Kim, J.-H., Choi, S.-H. & Lee, Y.-J. Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage. Exp. Mol. Med. 52, 781\u2013792 (2020).","journal-title":"Exp. Mol. Med."},{"key":"75810_CR27","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","volume":"179","author":"CM Heaphy","year":"2011","unstructured":"Heaphy, C. M. et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am. J. Pathol. 179, 1608\u20131615 (2011).","journal-title":"Am. J. Pathol."},{"key":"75810_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41525-023-00369-6","volume":"8","author":"R Sharaf","year":"2023","unstructured":"Sharaf, R. et al. A pan-sarcoma landscape of telomeric content shows that alterations in RAD51B and GID4 are associated with higher telomeric content. npj Genom. Med. 8, 26 (2023).","journal-title":"npj Genom. Med."},{"key":"75810_CR29","doi-asserted-by":"crossref","unstructured":"Ballinger, M. L. et al. Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science 379, 253\u2013260 (2023).","DOI":"10.1126\/science.abj4784"},{"key":"75810_CR30","unstructured":"Van der Auwera, G. A. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (\u2018O\u2019Reilly Media, Inc.\u2019, 2020)."},{"key":"75810_CR31","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1093\/bioinformatics\/btab135","volume":"37","author":"A Graubert","year":"2021","unstructured":"Graubert, A., Aguet, F., Ravi, A., Ardlie, K. G. & Getz, G. RNA-SeQC 2: efficient RNA-seq quality control and quantification for large cohorts. Bioinformatics 37, 3048\u20133050 (2021).","journal-title":"Bioinformatics"},{"key":"75810_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"75810_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"75810_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0352-z","volume":"15","author":"M Gershoni","year":"2017","unstructured":"Gershoni, M. & Pietrokovski, S. The landscape of sex-differential transcriptome and its consequent selection in human adults. BMC Biol. 15, 7 (2017).","journal-title":"BMC Biol."},{"key":"75810_CR35","unstructured":"Blighe, K., Rana, S. & Lewis, M. EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling. R package version 1.31.0, https:\/\/bioconductor.org\/packages\/EnhancedVolcano (2026)."},{"key":"75810_CR36","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"75810_CR37","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"75810_CR38","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv 060012 https:\/\/doi.org\/10.1101\/060012 (2016).","DOI":"10.1101\/060012"},{"key":"75810_CR39","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"75810_CR40","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","volume":"27","author":"K Cibulskis","year":"2011","unstructured":"Cibulskis, K. et al. ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics 27, 2601\u20132602 (2011).","journal-title":"Bioinformatics"},{"key":"75810_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"75810_CR42","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"75810_CR43","doi-asserted-by":"publisher","first-page":"E2423","DOI":"10.1002\/humu.22771","volume":"36","author":"AH Ramos","year":"2015","unstructured":"Ramos, A. H. et al. Oncotator: cancer variant annotation tool. Hum. Mutat. 36, E2423\u2013E2429 (2015).","journal-title":"Hum. Mutat."},{"key":"75810_CR44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin, R. et al. A universal SNP and small-indel variant caller using deep neural networks. Nat. Biotechnol. 36, 983\u2013987 (2018).","journal-title":"Nat. Biotechnol."},{"key":"75810_CR45","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1001\/jama.2020.20457","volume":"324","author":"SH AlDubayan","year":"2020","unstructured":"AlDubayan, S. H. et al. Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma. JAMA 324, 1957\u20131969 (2020).","journal-title":"JAMA"},{"key":"75810_CR46","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"75810_CR47","doi-asserted-by":"crossref","unstructured":"Gillani, R. et al. Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. Am. J. Hum. Genet. 109, 1026\u20131037 (2022).","DOI":"10.1016\/j.ajhg.2022.04.007"},{"key":"75810_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jamaoncol.2020.0197","volume":"6","author":"L Mirabello","year":"2020","unstructured":"Mirabello, L. et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol. 6, 724\u2013734 (2020).","journal-title":"JAMA Oncol."},{"key":"75810_CR49","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S1470-2045(16)30147-4","volume":"17","author":"ML Ballinger","year":"2016","unstructured":"Ballinger, M. L. et al. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol. 17, 1261\u20131271 (2016).","journal-title":"Lancet Oncol."},{"key":"75810_CR50","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"75810_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75810-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75810-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75810-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:02:47Z","timestamp":1787745767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75810-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75810"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75810-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.M.V.A. holds consulting roles with Tango Therapeutics, Genome Medical, Genomic Life, Enara Bio, Manifold Bio, Monte Rosa, Novartis Institute for Biomedical Research, Riva Therapeutics and Serinus Bio; he receives research support from Novartis, Bristol-Myers Squibb and Sanofi; he has equity in Tango Therapeutics, Genome Medical, Genomic Life, Syapse, Enara Bio, Manifold Bio, Microsoft, Monte Rosa, Riva Therapeutics and Serinus Bio; he has filed institutional patents on chromatin mutations, immunotherapy response, and methods for clinical interpretation. J.G.T.Z. reported ownership of stocks in the biotechnology exchange-traded funds CNCR, IDNA, IBB, and XBI; owns stocks in Novo Nordisk and GRAIL; and previously owned stocks in Adaptive Biotechnologies, 2seventy bio, and bluebird bio. R.G. has equity in Google, Microsoft, Amazon, Apple, Moderna, Pfizer, and Vertex Pharmaceuticals; his spouse is employed by Carrum Health. All other authors reported no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9032"}}